Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 2
1965 1
1968 2
1984 1
1988 1
1989 1
1990 3
1992 1
1994 1
1995 2
1997 3
1998 1
1999 3
2000 4
2001 3
2002 5
2003 25
2004 10
2005 12
2006 10
2007 13
2008 12
2009 15
2010 18
2011 20
2012 29
2013 27
2014 38
2015 29
2016 44
2017 33
2018 39
2019 57
2020 60
2021 78
2022 58
2023 74
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

666 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Galletti
Page 1
Rethinking breast cancer follow-up based on individual risk and recurrence management.
De Rose F, Meduri B, De Santis MC, Ferro A, Marino L, Colciago RR, Gregucci F, Vanoni V, Apolone G, Di Cosimo S, Delaloge S, Cortes J, Curigliano G. De Rose F, et al. Cancer Treat Rev. 2022 Sep;109:102434. doi: 10.1016/j.ctrv.2022.102434. Epub 2022 Jul 1. Cancer Treat Rev. 2022. PMID: 35933845 Free article. Review.
Reply to S. Di Cosimo et al.
Agostinetto E, Venet D, Ignatiadis M, Kalashnikova E. Agostinetto E, et al. JCO Precis Oncol. 2023 Jan;7:e2200644. doi: 10.1200/PO.22.00644. JCO Precis Oncol. 2023. PMID: 36701653 No abstract available.
Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial.
Di Cosimo S, Pérez-García JM, Bellet M, Dalenc F, Gil Gil MJ, Ruiz Borrego M, Gavilá J, Sampayo-Cordero M, Aguirre E, Schmid P, Marmé F, Gligorov J, Schneeweiss A, Albanell J, Zamora P, Wheatley D, Martínez-De Dueñas E, Carañana V, Amillano K, Mina L, Malfettone A, Cortés J, Llombart-Cussac A. Di Cosimo S, et al. Oncologist. 2023 Jan 18;28(1):23-32. doi: 10.1093/oncolo/oyac205. Oncologist. 2023. PMID: 36239405 Free PMC article. Clinical Trial.
Neck mass and tracheostomy in a young lady depicted by Piero di Cosimo.
Grau JJ, Caballero M, Garrido C, Canalda S, Trilla A. Grau JJ, et al. Hormones (Athens). 2020 Jun;19(2):261-264. doi: 10.1007/s42000-019-00146-0. Epub 2019 Nov 6. Hormones (Athens). 2020. PMID: 31696448 Review.
The first written description of the procedure is due to Brasavola, and dates from 1546. Piero di Cosimo (1462-1522) was an early Renaissance painter who painted a work traditionally known as Cephalus and Procris or The Death of Procris (1495-1500). ...
The first written description of the procedure is due to Brasavola, and dates from 1546. Piero di Cosimo (1462-1522) was an early Ren …
Response to Di Cosimo, Torri, and Porcu.
Trapp E, Janni W, Schindlbeck C, Jückstock J, Andergassen U, deGregorio A, Alunni-Fabbroni M, Tzschaschel M, Polasik A, Koch JG, Friedl TWP, Fasching PA, Haeberle L, Fehm T, Schneeweiss A, Beckmann MW, Pantel K, Mueller V, Rack B, Scholz C. Trapp E, et al. J Natl Cancer Inst. 2019 Nov 1;111(11):1234-1235. doi: 10.1093/jnci/djz095. J Natl Cancer Inst. 2019. PMID: 31187135 Free PMC article. No abstract available.
Erratum: Reply to S. Di Cosimo et al.
[No authors listed] [No authors listed] JCO Precis Oncol. 2023 Jun;7:e2300232. doi: 10.1200/PO.23.00232. JCO Precis Oncol. 2023. PMID: 37285562 No abstract available.
666 results